5 ml vial semaglutide Sema mg Hims & Hers launches compounded

There is currently no clinical evidence that it directly causes hair follicle damage or permanent hair loss

The study adds to mounting evidence of PFAS toxicity and could influence ongoing lawsuits and regulatory efforts

The SELECT trial showed that semaglutide reduced major cardiovascular events (heart attack, stroke, cardiovascular death) by 20% in people with obesity but without diabetes

However, the little research that exists shows a concerning link

Future research should prioritize multi-omics approaches to dissect subtype-specific molecular mechanisms of GABAergic interneurons and their interactions with other neurotransmitter systems (e.g., glutamatergic, serotonergic pathways)